Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
This colorectal tumor-on-chip model is an original and reliable platform for high-throughput drug screening and genetic expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Design and characterization of the microfluidic chip. (A) Profilometer characterization: 3D map of the microfluidic chip. Representative image of quality control and characterization of the microfluidic chip features. The central chamber is 5 mm in diameter and 126 μm in depth, with a separate inlet and outlet for hydrogel injection. The two lateral channels, each 100 μm in width and 126 μm in depth, are not interconnected, opening up the possibility of perfusing two distinct solutions. (B) Schematic of chip design and zoom-in image of the concept of colorectal tumor-on-a-chip model: Round microfluidic central chamber in which HCT-116 cancer cells are embedded in Matrigel; HCoMECs are seeded in the side channels to form a 3D vessel-like assembly. (C) Establishment of a microvascular 3D microenvironment of colorectal tumor-on-a-chip: HCT-116 CRC cells embedded in Matrigel (in central chamber, stained in red) and HCoMECs (in lateral microchannels, stained in yellow) at day 1 (1D) and day 5 (5D) of culture. Endothelial cells start to invade the central chamber filled with Matrigel in response to VEGF presence. (D) Fluorescence microscopy image of microfluidic lateral channel mimicking prevascularization with HCoMECs after 5 days of culture [4′,6-diamidino-2-phenylindole (DAPI) blue, nuclei; phalloidin green, F-actin filaments]. Representative fluorescence microscopy close-up image of microchannel cross section showing endothelial cells aligning and creating an endothelialized lumen within the microchannel.](https://figures.cochat.ai/paper-figures/e6920bdb0956445d8d19309ea14d3e31/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-1.jpg)

![Fig. 3 Schematic representation of fluorescent nanoparticle gradient formation. (A) Transmission electron microscopy image of individual CMCht/PAMAM dendrimer nanoparticle, representative image of chip connected to tubing perfusing the nanoparticle solution, and zoom-in confocal microscopy image confirming FITC-labeled CMCht/PAMAM dendrimer nanoparticles’ dispersion in Matrigel. (B) Panel of fluorescence microscopy images of FITC-labeled nanoparticle gradient up to 12 hours. (C) Quantification of fluorescence: Intensity [in arbitrary units (a.u.)] versus distance (in micrometers) across the chip up to 12 hours [measurements according to the direction of the green arrow indicated in (B)]. (D) 3D projection of FITC-labeled nanoparticle gradient according to fluorescence intensity.](https://figures.cochat.ai/paper-figures/708a4d00001f4aab95398541a1dadede/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-3.jpg)
![Fig. 4 GEM drug effect on colorectal tumor model. (A) Release profile of GEM: Cumulative release (in hours) of GEM at pH 7.4 in phosphate-buffered saline (PBS), at 37°C and stirred at 60 rpm, determined by ultraviolet (UV) spectrophotometer set to 275 nm. The results are expressed as means ± SD (n = 6). (B) Schematic representation of experimental setup [perfusion of culture medium through one inlet and one outlet and of culture medium supplemented with GEM-loaded dendrimer nanoparticles (0.5 mg/ml) through the other inlet and outlet]; the areas defined for cell death quantification are delimited by dashed lines, and each ring is assigned D1 to D3 and M1 to M3. (C) Representative images of fluorescence microscopy images of live/dead assay performed on microfluidic chip at days 1 and 5. (D) Quantification of cell death, represented as percentage, based on the microscopy data. Data are presented as means ± SD (n = 3). The asterisk (*) denotes statistical differences (P < 0.05). Scale bars, 1000 μm. NP, nanoparticle; CTRL, control.](https://figures.cochat.ai/paper-figures/27813f8b3257452bb0dbcf8a091e4f62/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-4.jpg)
![Fig. 5 Gene expression analysis and immunocytochemistry on a chip. (A) Representation of hydrogel retrieval containing HCT-116 cells from the chip for gene expression analysis. (B) Gene expression of Ki-67, Casp-3, and MMP-1, in the absence (control) and presence of GEM, at days 1 and 5. The values for controls are represented by the dashed line. The asterisk (*) indicates significant differences when comparing the same condition at two different time points. The hash key (#) indicates significant differences when comparing to controls at the same time point. Data represent mean values of three independent experiments ± SD. RPS27A, ribosomal protein S27A. (C) Immunohistochemistry: In the center, a representative schematic of the entire chip that has reused an image from Fig. 4C (GEM NP gradient, top left) is depicted. The lateral images represent the zoom in at the cell level showing the immunocytochemistry Ki-67 staining after 5 days in culture [panels showing DAPI nuclei staining (blue), Ki-67 staining (green), F-actin staining (red), and merged image in colors].](https://figures.cochat.ai/paper-figures/67019409de02432a8df9bda6665dcdc4/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The platform was inspired by radial drug penetration (diffusion of small molecules from the outer boundaries into the central core of the tumor) into solid tumors, and it evaluated in real-time the interactions between colorectal cancer cells and endothelial cells that in fi ltrated the VEGF-infused tumor core [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To mimic the human colorectal TME and reconstitute functions of the microvascular tissue, a 3D micro fl uidic chipbased in vitro model was fabricated [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
In the citing paper
“The microvascularized colorectal-tumor-on-a-chip model was developed to investigate sprouting formation and drug screening applications.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
In the citing paper
“CRC cells, labeled in red, and HCoMECs, in yellow, respond to the incoming VEGF growth factor.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434 · cited 1×
“Angiogenesis is a complex morphogenetic process where endothelial cells from preexisting vessels invade the matrix as multicellular sprouts to form new vessels (29).”
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions
Chen, X.-G., & Park, H.-J. (2003) · Carbohydrate Polymers · doi:10.1016/s0144-8617(03)00051-1 · Cited by 784
Biomolecular gradients in cell culture systems
Keenan, T. M., & Folch, A. (2008) · Lab Chip · doi:10.1039/b711887b · Cited by 596
Filopodia in cell adhesion, 3D migration and cancer cell invasion
Jacquemet, G., Hamidi, H., & Ivaska, J. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.007 · Cited by 533
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Cited by
Patient-derived xenograft models in cancer therapy: technologies and applications
Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01419-2 · Cited by 494
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
“To mimic the human colorectal TME and reconstitute functions of the microvascular tissue, a 3D microfluidic chipbased in vitro model was fabricated [72].”
BackgroundMethodSelf-citationTumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
“Furthermore, the effects of different growth factors (GFs) or drugs in a biomimetic microenvironment and stromadriven ECM remodeling can also be studied using these microfluidic chip-based in vitro 3D models with a high degree of monitoring [240, 241].”
BackgroundOrgan-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
“At present, tumor OoCs also include colorectal [55, 140], ovarian [141, 142], prostate [143, 144], bladder [145, 146], cervical [147, 148], gastric [56, 149], and skin [150, 151] cancer.”
BackgroundTumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Organs-on-a-chip models for biological research
Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M. (2021) · Cell · doi:10.1016/j.cell.2021.08.005 · Cited by 248
“Suchmodels are becoming invaluable for assessing the efficacy of drug-loaded nanoparticles in emerging therapies (Figure 4D) (Carvalho et al., 2019a).”
BackgroundAdvances in Engineering Human Tissue Models
Moysidou, C.-M., Barberio, C., & Owens, R. M. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.620962 · Cited by 179
“, 2018) and cancer (Ayuso et al., 2016; Hassell et al., 2017; Hao et al., 2018; Carvalho et al., 2019), as well as for the interaction of multiple organs, as first showcased by Shuler et al.”
BackgroundOrgan‐on‐a‐Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine
Rodrigues, R. O., Sousa, P. C., Gaspar, J., Bañobre‐López, M., Lima, R. A., & Minas, G. M. H. (2020) · Small · doi:10.1002/smll.202003517 · Cited by 144
Emerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 127
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
Advances in Spheroids and Organoids on a Chip
Fang, G., Chen, Y., Lu, H., & Jin, D. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202215043 · Cited by 141
Dendrimer nanoparticles for colorectal cancer applications
Carvalho, M. R., Reis, R. L., & Oliveira, J. M. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02289a · Cited by 136
Self-citationHuman Organs-on-Chips for Virology
Tang, H., Abouleila, Y., Si, L., Ortega-Prieto, A. M., Mummery, C. L., Ingber, D. E., & Mashaghi, A. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.06.005 · Cited by 113
“However, models of small-intestine [41] and large-intestine [42,43] on chips have been successful in studying associated physiological and pathological processes (i.”
BackgroundEngineering Hydrogels for the Development of Three-Dimensional In Vitro Models
Maji, S., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052662 · Cited by 122
Functionally Graded Biomaterials for Use as Model Systems and Replacement Tissues
Lowen, J. M., & Leach, J. K. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909089 · Cited by 109
Organ-on-a-chip engineering: Toward bridging the gap between lab and industry
Ramadan, Q., & Zourob, M. M. (2020) · Biomicrofluidics · doi:10.1063/5.0011583 · Cited by 113
Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
Bhattacharya, S., Calar, K., & de la Puente, P. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01583-1 · Cited by 99
Organ-On-Chip Technology: The Future of Feto-Maternal Interface Research?
Richardson, L., Kim, S., Menon, R., & Han, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00715 · Cited by 107
“These systems allow researchers to test many different biomolecular factors under a more physiologically relevant in vitro environment, leading to a better understanding of human physiology through gathering significant amounts of data much faster and potentially much more cost-effectively (Huh, 2015; Maschmeyer et al…”
BackgroundMethodElectrospun nanofibers in cancer research: from engineering of in vitro 3D cancer models to therapy
Cavo, M., Serio, F., Kale, N. R., D'Amone, E., Gigli, G., & del Mercato, L. L. (2020) · Biomaterials Science · doi:10.1039/d0bm00390e · Cited by 97
Organ-on-a-chip technology for nanoparticle research
Kang, S., Park, S. E., & Huh, D. (2021) · Nano Convergence · doi:10.1186/s40580-021-00270-x · Cited by 108
Saha, B., Mathur, T., Tronolone, J. J., Chokshi, M., Lokhande, G. K., Selahi, A., Gaharwar, A. K., Afshar-Kharghan, V., Sood, A. K., Bao, G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5283 · Cited by 90
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Tian, C., Zheng, S., Liu, X., & Kamei, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01552-0 · Cited by 101
“Reproduced with permission [54], Copyright 2019, AAAS publications”
MethodFrom Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Huang, Y., Liu, T., Huang, Q., & Wang, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00004 · Cited by 109
Microfluidic high-throughput 3D cell culture
Ko, J., Park, D., Lee, J., Jung, S., Baek, K., Sung, K. E., Lee, J., & Jeon, N. L. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00163-8 · Cited by 88
“For example, microfluidic cell culture devices enable various assessments, including phenotypic 19,170 , genomic 195,196 , proteomic 197,198 and histological analyses 199 .”
Radhakrishnan, J., Varadaraj, S., Dash, S. K., Sharma, A., & Verma, R. S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.002 · Cited by 91
Intestinal organ chips for disease modelling and personalized medicine
Özkan, A., LoGrande, N., Feitor, J. F., Goyal, G., & Ingber, D. E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00968-3 · Cited by 109
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 93
“Novel targeted drug like galunisertib, a TGFβR1 antagonist, finished in phase II clinical trials for hepatocellular cancer, was also tested in VMT loading with SW480 and HCT116 attributed to the presence of fibroblasts in the microenvironment [78] In addition, drug delivery and penetration have been performed in simil…”
BackgroundA 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance
Reidy, E., Leonard, N. A., Treacy, O., & Ryan, A. E. (2021) · Cancers · doi:10.3390/cancers13020227 · Cited by 92
Strelez, C., Chilakala, S., Ghaffarian, K., Lau, R., Spiller, E. R., Ung, N. M., Hixon, D., Yoon, A. Y., Sun, R., Lenz, H., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102509 · Cited by 91
“In addition, the tissue-tissue interface of the Organ Chips also supports the performance of drug treatment studies in a physiological manner by flowing drugs through the endothelial channel and measuring tumor cell response in the epithelial channel as seen in previous reports (Carvalho et al., 2019).”
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, G., Lu, H., Al-Nakashli, R., Chapman, R., Zhang, Y., Ju, L. A., Lin, G., Stenzel, M. H., & Jin, D. (2022) · Biofabrication · doi:10.1088/1758-5090/ac2ef9 · Cited by 77
Microfluidic lumen-based systems for advancing tubular organ modeling
Virumbrales-Muñoz, M., Ayuso, J. M., Gong, M. M., Humayun, M., Livingston, M. K., Lugo-Cintrón, K. M., McMinn, P., Álvarez-García, Y. R., & Beebe, D. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00705f · Cited by 76
Human‐on‐Leaf‐Chip: A Biomimetic Vascular System Integrated with Chamber‐Specific Organs
Mao, M., Bei, H. P., Lam, C. H., Chen, P., Wang, S., Chen, Y., He, J., & Zhao, X. (2020) · Small · doi:10.1002/smll.202000546 · Cited by 71
Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review
Gonçalves, I. M., Carvalho, V. M., Rodrigues, R. O., Pinho, D., Teixeira, S., Moita, A., Hori, T., Kaji, H., Lima, R. A., & Minas, G. M. H. (2022) · Cancers · doi:10.3390/cancers14040935 · Cited by 81
“[47] described a tumor-on-a-chip model to evaluate the efficacy of drug-loaded nanoparticles in the treatment of colorectal carcinoma.”
BackgroundDesign and engineering of organ-on-a-chip
Cho, S., Lee, S., & Ahn, S. I. (2023) · Biomedical Engineering Letters · doi:10.1007/s13534-022-00258-4 · Cited by 78
Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues
Hwangbo, H., Chae, S., Kim, W.-J., Jo, S., & Kim, G. (2023) · Theranostics · doi:10.7150/thno.90093 · Cited by 73
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Liu, X., Su, Q., Zhang, X., Yang, W., Ning, J., Jia, K., Xin, J., Li, H., Yu, L., Liao, Y., et al. (2022) · Biosensors · doi:10.3390/bios12111045 · Cited by 75
Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy
Iranpour, S., Bahrami, A. R., Saljooghi, A. S., & Matin, M. M. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213949 · Cited by 67
Organoids and Colorectal Cancer
Barbáchano, A., Fernández‐Barral, A., Bustamante‐Madrid, P., Prieto, I., Rodríguez-Salas, N., Larriba, M. J., & Múñoz, A. (2021) · Cancers · doi:10.3390/cancers13112657 · Cited by 81
Requirements for Animal Experiments: Problems and Challenges
Fontana, F., Figueiredo, P., Martins, J. P., & Santos, H. A. (2020) · Small · doi:10.1002/smll.202004182 · Cited by 68
Establishment of Colorectal Cancer Organoids in Microfluidic-Based System
Pinho, D., Santos, D., Vila, A., & Carvalho, S. (2021) · Micromachines · doi:10.3390/mi12050497 · Cited by 59
“ported to generate internal shear stress supported by the Matrigel blob [29,30].”
BackgroundMethodCastro, F., Pereira, C. L., Macedo, M. H., Almeida, A., Silveira, M. J., Dias, S., Cardoso, A. P., Oliveira, M. J., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.06.001 · Cited by 66
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 67
Peptide‐Modified Dendrimer Nanoparticles for Targeted Therapy of Colorectal Cancer
Carvalho, M. R., Carvalho, C. R., Maia, F. R., Caballero, D., Kundu, S. C., Reis, R. L., & Oliveira, J. M. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900132 · Cited by 57
Self-citationRecent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Chi, C., Lao, Y., Ahmed, A. H. R., Benoy, E. C., Li, C., Dereli‐Korkut, Z., Fu, B. M., Leong, K. W., & Wang, S. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000880 · Cited by 64
Le, C., Bennasroune, A., Langlois, B., Salesse, S., Boulagnon‐Rombi, C., Morjani, H., Dedieu, S., & Appert-Collin, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00527 · Cited by 61
“In this model, human colonic microvascular endothelial cells cultivated in a 3D vessel-mimetic device are attached to the wall of the lateral channels of themicrofluidic chip whereas HCT-116 cells are embedded in collagen IV-enriched Matrigel in the central chamber (88).”
MethodTumor-microenvironment-on-a-chip: the construction and application
Xu, H., Wen, J., Yang, J., Zhou, S., Li, Y., Xu, K., Li, W., & Li, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01884-4 · Cited by 65
“…in colorectal cancer (CRC) and the current need to improve the delivery efficiency of anticancer drugs, Carvalho et al. developed a 3D microfluidic chip model that can simulate the colorectal tumor microenvironment and evaluate the dynamic delivery efficiency of anticancer drug nanoparticles [120].”
BackgroundOrgan-on-a-Chip: Opportunities for Assessing the Toxicity of Particulate Matter
Yang, J.-W., Shen, Y., Lin, K.-C., Cheng, S.-J., Chen, S.-L., Chen, C., Kumar, P. V., Lin, S., Lu, H.-E., & Chen, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00519 · Cited by 58
“…to provide more clues to accelerate the clarification of the human toxicity of PM deposition, penetration and metabolism (Yuancheng et al., 2018; Carvalho et al., 2019), especially for the specific examples of lung- heart- on chip model, which could be used to investigate the systemic…”
BackgroundBeyond PDMS and Membranes: New Materials for Organ-on-a-Chip Devices
Radisic, M., & Loskill, P. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00831 · Cited by 61
Mintz, R. L., Lao, Y., Chi, C., He, S., Li, M., Quek, C. H., Shao, D., Chen, B., Han, J., Wang, S., et al. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10152 · Cited by 53
Wang, Y., Yung, P. S., Lü, G., Liu, Y., Ding, C., Mao, C., Li, Z. A., & Tuan, R. S. (2024) · Advanced Materials · doi:10.1002/adma.202401334 · Cited by 60
Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
Gil, J. F., Moura, C. S., Silvério, V., Gonçalves, G., & Santos, H. A. (2023) · Advanced Materials · doi:10.1002/adma.202300692 · Cited by 48
Organ-on-chip systems as a model for nanomedicine
Stavrou, M., Phung, N. B., Grimm, J., & Andreou, C. (2023) · Nanoscale · doi:10.1039/d3nr01661g · Cited by 50
Al-Kabani, A., Huda, B., Haddad, J., Yousuf, M., Bhurka, F., Ajaz, F., Patnaik, R., Jannati, S., & Banerjee, Y. (2025) · Cancers · doi:10.3390/cancers17132163 · Cited by 56
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
Ramzy, G. M., Koessler, T., Ducrey, E., McKee, T., Ris, F., Buchs, N. C., Rubbia‐Brandt, L., Dietrich, P., & Nowak-Sliwinska, P. M. (2020) · Cancers · doi:10.3390/cancers12061423 · Cited by 47
“employed OOC technology to recapitulate the human colorectal tumor microenvironment, and assess the efficacy of gemcitabine loaded nanoparticles for the treatment of CRC using a microfluidic gradient [99].”
MethodShen, P., Jia, Y., Zhou, W., Zheng, W., Wu, Y., Qu, S., Du, S., Wang, S., Shi, H., Sun, J., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.04.010 · Cited by 42
“Therefore, it is on great demand to utilize the specific microfluidic chip model to study the detailed crosstalk between cancer cells and HSCs in tumor progression by integrating tumor microvasculature and tumor-stromal microenvironment factors 16 e 19 .”
BackgroundMethodPaun, R. A., Jurchuk, S., & Tabrizian, M. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10601 · Cited by 57
“276,277 Recently, an interesting study using theranostic doxorubicin-loaded and HER2-targeted liposomes showed that drug deposition in metastatic breast cancer tumors varied significantly even within the same patient, depending on the tumor type and location.”
BackgroundEngineering complexity in human tissue models of cancer
Ronaldson-Bouchard, K., Baldassarri, I., Tavakol, D. N., Graney, P. L., Samaritano, M., Cimetta, E., & Vunjak‐Novakovic, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114181 · Cited by 44
Microscopic Imaging Methods for Organ-on-a-Chip Platforms
Buchanan, B. C., & Yoon, J. (2022) · Micromachines · doi:10.3390/mi13020328 · Cited by 44
“Fluorescent images can be taken from these tumor on a chip devices to ensure the formations of the correct 3D microvascular environment [73] and desired cell structure [74] before testing therapeutics and drugs in the device.”
BackgroundCancer-on-chip: a 3D model for the study of the tumor microenvironment
Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 51
On-Chip Replication of Extremely Early-Stage Tumor Behavior
Li, C., Li, S., Du, K., Li, P., Qiu, B., & Ding, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c03740 · Cited by 40
Cancer Metastasis‐on‐a‐Chip for Modeling Metastatic Cascade and Drug Screening
Brooks, A., Zhang, Y., Chen, J., & Zhao, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302436 · Cited by 44
Carvalho, V. M., Bañobre‐López, M., Minas, G. M. H., Teixeira, S., Lima, R. A., & Rodrigues, R. O. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00224 · Cited by 44
Vascularized organoid-on-a-chip: design, imaging, and analysis
Yu, T., Yang, Q., Peng, B., Gu, Z., & Zhu, D. Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09905-z · Cited by 37
In Vitro Models of Biological Barriers for Nanomedical Research
Carton, F., & Malatesta, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168910 · Cited by 34
Advances in the Model Structure of In Vitro Vascularized Organ-on-a-Chip
Yin, H., Wang, Y., Liu, N., Zhong, S., Li, L., Zhang, Q., Liu, Z., & Yue, T. (2024) · Cyborg and Bionic Systems · doi:10.34133/cbsystems.0107 · Cited by 43
“[101] developed a 3D microfluidic model (Fig.”
Luque‐González, M. A., Reis, R. L., Kundu, S. C., & Caballero, D. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000045 · Cited by 36
Self-citationOn-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
In situ biosensing technologies for an organ-on-a-chip
Kim, J., Kim, J., Jin, Y., & Cho, S. (2023) · Biofabrication · doi:10.1088/1758-5090/aceaae · Cited by 36
Advances in Modeling the Immune Microenvironment of Colorectal Cancer
Yoon, P., Piccolo, N. D., Shirure, V. S., Peng, Y., Kirane, A., Canter, R. J., Fields, R. C., George, S. C., & Gholami, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614300 · Cited by 35
Wu, Y., Zhou, Y., Qin, X., & Liu, Y. (2021) · Biomicrofluidics · doi:10.1063/5.0062697 · Cited by 37
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Williams, S. T., Wells, G., Conroy, S., Gagg, H., Allen, R. J., Rominiyi, O., Helleday, T., Hullock, K., Pennington, C. E. W., Rantala, J., et al. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.32 · Cited by 37
Park, J., Kim, S., Hong, J., & Jeon, J. S. (2022) · Lab on a Chip · doi:10.1039/d2lc00597b · Cited by 33
Wang, R., Zhang, C., Li, D., & Yao, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1057913 · Cited by 33
Ko, J., Hyung, S., Heo, Y. J., Jung, S., Kim, S. T., Park, S. H., Hong, J. Y., Lim, S. H., Kim, K., Yoo, S., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122504 · Cited by 33
Tumor‐On‐A‐Chip Models for Predicting In Vivo Nanoparticle Behavior
de Roode, K. E., Hashemi, K., Verdurmen, W. P. R., & Brock, R. E. (2024) · Small · doi:10.1002/smll.202402311 · Cited by 34
In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?
Trujillo, S. C., Ferrer, G. G., & Ribelles, J. L. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165747 · Cited by 35
Ong, L. J. Y., Chia, S., Wong, S. Q. R., Zhang, X., Chua, H., Loo, J. M., Chua, W. Y., Chua, C., Tan, E., Hentze, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.952726 · Cited by 31
Three‐dimensional multicellular biomaterial platforms for biomedical application
Hao, J., Chen, Q., & Wu, C. (2023) · Interdisciplinary materials · doi:10.1002/idm2.12122 · Cited by 36
“Therefore, microfluidic multicellular platforms are also widely used in drug screening, [102] viral infection, [103,104] nanoparticles effectiveness, [105] and other aspects.”
BackgroundSpheroids and organoids derived from colorectal cancer as tools for in vitro drug screening
Zawawi, S. S. A., Salleh, E. A., & Musa, M. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00226 · Cited by 27
Artificial Intelligence for Organoids Multidimensional Assessment
Mo, Y., Wang, J., Yang, H., Bai, L., Xu, K., & Su, J. (2025) · SmartMat · doi:10.1002/smm2.70016 · Cited by 29
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Kee, J. X., Yau, J. N. N., Muthuramalingam, R. P. K., Wang, X., Chng, W. H., Lopez‐Sanchez, A., Tay, K. K. W., Deng, L., Gibson, D., Bertrand, H. C., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00041 · Cited by 35
Advances in screening hyperthermic nanomedicines in 3D tumor models
Soeiro, J. F., Sousa, F. L., Monteiro, M. V., Gaspar, V. M., Silva, N. J. O., & Mano, J. F. (2024) · Nanoscale Horizons · doi:10.1039/d3nh00305a · Cited by 30
Skubal, M., Larney, B. M., Phung, N. B., Desmaras, J. C., Dozic, A. V., Volpe, A., Ogirala, A., Machado, C. M. L., Djibankov, J., Ponomarev, V., et al. (2024) · Theranostics · doi:10.7150/thno.95334 · Cited by 26
Momoli, C., Costa, B., Lenti, L., Tubertini, M., Parenti, M., Martella, E., Varchi, G., & Ferroni, C. (2025) · Cancers · doi:10.3390/cancers17040700 · Cited by 24
In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
Salata, G. C., Hirokawa, C. M., de Melo, G. B., Malagó, I. D., Nunes, J. R., Passos, J. S., Daré, R. G., & Lopes, L. B. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00321-6 · Cited by 26
Li, M., Song, X., Jin, S., & Ye, K. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00134-7 · Cited by 25
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
“Moreover, microfluidics only require a small substance input [16].”
BackgroundPandey, G., Shah, S., Phatale, V., Khairnar, P., Kolipaka, T., Famta, P., Jain, N., Srinivasarao, D. A., Asthana, A., Raghuvanshi, R. S., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105249 · Cited by 28
Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture Dishes
Avolio, M., & Trusolino, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1531 · Cited by 26
Advances in microfluidic 3D cell culture for preclinical drug development
(2022) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2021.07.022 · Cited by 23
Cancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling
Nejati, B., Shahhosseini, R., Hajiabbasi, M., Ardabili, N. S., Baktash, K. B., Alivirdiloo, V., Moradi, S., Rad, M. F., Rahimi, F., Farani, M. R., et al. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03199-5 · Cited by 29
“This platform also allows analysis at the gene expression level, and downregulation of all genes examined (caspase-3, MMP-1, and Ki-67) was detected [67].”
Sánchez-Salazar, M. G., Oliver, R. C.-L., Ramos-Meizoso, S., Jerezano-Flores, V. S., Gallegos-Martínez, S., Bolívar‐Monsalve, E. J., Ceballos‐González, C. F., Santiago, G. T., & Álvarez, M. M. (2023) · Bioengineering · doi:10.3390/bioengineering10050554 · Cited by 26
“Previous preclinical and clinical studies have demonstrated that VEGF is the main angiogenic factor in human colorectal cancer and is associated with metastatic events and poor patient prognosis [17].”
BackgroundMethodInfluentialVascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
“Finally, dendrimer NPs loaded with gemcitabine showed a successful release of the drug in a VTM and pinpointed a possible threshold in drug efficacy, giving a stark increase in cell viability after the first hundreds of micrometers of NPs diffusion in the vessel [85].”
MethodMechanoimmunology in the solid tumor microenvironment
Golo, M., Newman, P. L. H., Kempe, D., & Biro, M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231427 · Cited by 25
Recapitulating Tumor Hypoxia in a Cleanroom-Free, Liquid-Pinning-Based Microfluidic Tumor Model
Oh, J. M., Begum, H. M., Liu, Y. L., Ren, Y., & Shen, K. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00207 · Cited by 23
Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity
Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 26
Metadata
- Authors
- Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P.
- Affiliations
- 3B's Research Group (PT)
- Maastricht University (NL)
- Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.
- Corresponding author
- Oliveira, J. M.
- ORCID
- Venue
- Science Advances
- Published
- 2019-05-03
- Volume
- 5
- Issue
- 5
- Pages
- eaaw1317-eaaw1317
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6531003
- OpenAlex
- W2946416309
- Cited by
- 230
- References
- 49
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 44 · 2023: 40 · 2022: 32 · 2021: 38 · 2020: 29 · 2019: 3
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- EMBO (Short-Term Fellowship 7232)
- FCT (NORTE-01-0145-FEDER-000023, IF/01285/2015)
- Norte Portugal Regional Operational Programme (NORTE-08-5369-FSE- 000044)
- IET A F Harvey Engineering (IET A F Harvey Engineering Research Prize 2018 (ENG ThE CANCER))
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- colorectal cancer, tumor-on-a-chip, 3D tumor models, precision nanomedicine, precision oncology, cancer nanomedicine
- MeSH terms
- Cell Survival, Humans, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Coculture Techniques, Ki-67 Antigen, Matrix Metalloproteinase 1, Imaging, Three-Dimensional, Biomimetics, Microfluidics, HCT116 Cells, Cell Line, Tumor, Dendrimers, Nanomedicine, Caspase 3, Nanoparticles, Lab-On-A-Chip Devices, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.